This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Original article
Cohen, S. H. et al. Extended follow-up of microbiome therapeutic SER-109 through 24 weeks for recurrent Clostridioides difficile infection in a randomized clinical trial. JAMA https://doi.org/10.1001/jama.2022.16476 (2022)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hindson, J. Follow-up of SER-109 for recurrent C. difficile. Nat Rev Gastroenterol Hepatol 19, 752 (2022). https://doi.org/10.1038/s41575-022-00710-x
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41575-022-00710-x